CPT: Pharmacometrics & Systems Pharmacology (May 2019)

Misidentification Subtype of Alzheimer's Disease Psychosis Predicts a Faster Cognitive Decline

  • Fabrizia D'Antonio,
  • Suzanne Reeves,
  • Yucheng Sheng,
  • Emma McLachlan,
  • Carlo deLena,
  • Robert Howard,
  • Julie Bertrand

DOI
https://doi.org/10.1002/psp4.12389
Journal volume & issue
Vol. 8, no. 5
pp. 308 – 315

Abstract

Read online

The presence of psychosis is associated with a more rapid decline in Alzheimer's disease (AD), but the impact of paranoid (persecutory delusions) and misidentification (misperceptions and/or hallucinations) subtypes of psychosis on the speed of decline in AD is still unclear. We analyzed data on Alzheimer's Disease Neuroimaging Initiative 2 participants with late mild cognitive impairment or AD, and we described individual trajectories of Alzheimer's Disease Assessment Scale–Cognitive Subscale scores using a semimechanistic logistic model with a mixed effects–based approach, which accounted for dropout and adjusted for baseline Mini Mental State Examination scores. The covariate model included psychosis subtypes, age, gender, education, medications, and Apolipoprotein E epsilon 4 (Apo‐e ε4 genotype). We found that the Alzheimer's Disease Assessment Scale–Cognitive Subscale rate of increase was doubled in misidentification (βr,misid_subtype = 0.63, P = 0.031) and mixed (both subtypes; βr,mixed_subtype = 0.70, P = 0.003) when compared with nonpsychotic (or paranoid) patients, suggesting that the misidentification subtype may represent a distinct AD sub‐phenotype associated with an accelerated pathological process.